Prostate-Derived ETS Factor Regulates Epithelial-to-Mesenchymal Transition through Both SLUG-Dependent and Independent Mechanisms.

The 5-year survival rate is very low when breast cancer becomes metastatic. The metastatic process is governed by a network of molecules of which SLUG is known to play a major role as a regulator of epithelial-to-mesenchymal transition (EMT). Prostate-derived ETS factor (PDEF) has been proposed as a tumor suppressor, possibly through inhibition of invasion and metastasis; therefore, understanding the mechanism of PDEF regulation may help to better understand its role in breast cancer progression. This study shows for the first time that the transcription factor SLUG is a direct target of PDEF in breast cancer. We show that the expression of PDEF is able to suppress/dampen EMT through the negative regulation of SLUG. In addition, we show that PDEF is also able to regulate downstream targets of SLUG, namely E-cadherin, in both SLUG-dependent and -independent manners, suggesting a critical role for PDEF in regulating EMT.

[1]  V. Findlay,et al.  ETS Transcription Factor Expression and Conversion During Prostate and Breast Cancer Progression , 2010 .

[2]  K. Briegel,et al.  Molecular characterization of TGFbeta-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells. , 2010, Biochemical and biophysical research communications.

[3]  I. Fidler,et al.  AACR centennial series: the biology of cancer metastasis: historical perspective. , 2010, Cancer research.

[4]  Xin-Hua Feng.  The changing faces of cancer cells , 2010, Nature Reviews Molecular Cell Biology.

[5]  R. Weinberg,et al.  Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[6]  David P Turner,et al.  Transcriptional Regulation of p21/CIP1 Cell Cycle Inhibitor by PDEF Controls Cell Proliferation and Mammary Tumor Progression* , 2010, The Journal of Biological Chemistry.

[7]  R. Meacham,et al.  Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEF , 2010, Molecular Cancer.

[8]  David P Turner,et al.  PDEF is a negative regulator of colon cancer cell growth and migration , 2009, Journal of cellular biochemistry.

[9]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[10]  Paula D. Bos,et al.  Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.

[11]  H. Hoefler,et al.  Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. , 2009, Frontiers in bioscience.

[12]  David P Turner,et al.  MicroRNA-mediated inhibition of prostate-derived Ets factor messenger RNA translation affects prostate-derived Ets factor regulatory networks in human breast cancer. , 2008, Cancer research.

[13]  K. Odunsi,et al.  Prostate‐derived Ets transcription factor as a favorable prognostic marker in ovarian cancer patients , 2008, International journal of cancer.

[14]  V. Findlay,et al.  Global gene expression analysis identifies PDEF transcriptional networks regulating cell migration during cancer progression. , 2008, Molecular biology of the cell.

[15]  D. Radisky,et al.  Epithelial-mesenchymal transition and the stem cell phenotype. , 2008, Cell stem cell.

[16]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[17]  E. Lander,et al.  Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. , 2008, Cancer research.

[18]  N. Hotchin,et al.  Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. , 2008, World journal of gastroenterology.

[19]  Gema Moreno-Bueno,et al.  Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.

[20]  L. Montanaro,et al.  The basal‐like breast carcinoma phenotype is regulated by SLUG gene expression , 2008, The Journal of pathology.

[21]  M. Bhasin,et al.  Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells. , 2007, Cancer research.

[22]  David P Turner,et al.  Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer. , 2007, Cancer research.

[23]  Fengzhi Li,et al.  Prostate-derived Ets transcription factor (PDEF) downregulates survivin expression and inhibits breast cancer cell growth in vitro and xenograft tumor formation in vivo , 2007, Breast Cancer Research and Treatment.

[24]  G. Daley,et al.  Novel role for PDEF in epithelial cell migration and invasion. , 2005, Cancer research.

[25]  A. Seth,et al.  ETS transcription factors and their emerging roles in human cancer. , 2005, European journal of cancer.

[26]  A. Brasier,et al.  Two-step cross-linking method for identification of NF-kappaB gene network by chromatin immunoprecipitation. , 2005, BioTechniques.

[27]  Keith R. Johnson,et al.  Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition , 2005, Journal of Cell Science.

[28]  Avri Ben-Ze'ev,et al.  Autoregulation of E-cadherin expression by cadherin–cadherin interactions , 2003, The Journal of cell biology.

[29]  V. Sementchenko,et al.  Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression. , 2003, Cancer research.

[30]  V. Sementchenko,et al.  The epithelial-specific Ets factors occupy a unique position in defining epithelial proliferation, differentiation and carcinogenesis. , 2003, Anticancer research.

[31]  B. Wold,et al.  p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells , 2003, Oncogene.

[32]  M. Nieto,et al.  The snail superfamily of zinc-finger transcription factors , 2002, Nature Reviews Molecular Cell Biology.

[33]  A. Sood,et al.  Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[34]  H. Moses,et al.  Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. , 2001, Molecular biology of the cell.

[35]  P. Romeo,et al.  Analysis of the thrombopoietin receptor (MPL) promoter implicates GATA and Ets proteins in the coregulation of megakaryocyte-specific genes. , 1996, Blood.

[36]  W. Isaacs,et al.  Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. , 1994, Cancer research.

[37]  P. Romeo,et al.  Structure and transcription of the human c-mpl gene (MPL). , 1994, Genomics.

[38]  M. Takeichi,et al.  Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. , 1993, Cancer research.

[39]  E. Hay,et al.  Cell contact during early morphogenesis in the chick embryo. , 1967, Developmental biology.